Showing 1 - 3 results of 3 for search 'Robin Soetekouw', query time: 0.02s Refine Results
  1. 1
    Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands

    Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands by Annemarie J.S. Winkelhagen, Theo Mank, Peter J. de Vries, Robin Soetekouw

    Published 2012-06-01
    Get full text
    Article
  2. 2
    No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

    No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. by Marlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E van der Ende, Robin Soetekouw, Frank de Wolf, Joep M A Lange, Hanneke Schuitemaker, Jan M Prins, Primo-SHM Study Group

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

    Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial. by Steven F L van Lelyveld, Julia Drylewicz, Maaike Krikke, Ellen M Veel, Sigrid A Otto, Clemens Richter, Robin Soetekouw, Jan M Prins, Kees Brinkman, Jan Willem Mulder, Frank Kroon, Ananja Middel, Jori Symons, Jori Symons, Annemarie M J Wensing, Monique Nijhuis, José A M Borghans, Kiki Tesselaar, Andy I M Hoepelman, MIRS study group

    Published 2015-01-01
    Get full text
    Article

Search Tools: